Hypoglycaemia in diabetes

The unifying teaching point is that hypoglycaemia is the single greatest barrier to safe intensive insulin therapy. The Diabetes Control and Complications Trial proved that intensive control prevents long-term microvascular complications, but at the price of a threefold increase in severe hypoglycaemia — a finding that reshaped paediatric diabetes care into a constant negotiation between lowering the HbA1c and protecting the brain. [4] [1]

Overview & Definition

Hypoglycaemia in diabetes is a low blood glucose produced by the imbalance between insulin action and available substrate — too much insulin, too little food, too much exercise, or a combination of all three. The threshold at which harm begins is lower than the threshold at which symptoms appear, which is why the ISPAD guidelines define a glucose below 3.9 millimoles per litre (70 milligrams per decilitre) as an alert value that should prompt review, and below 3.0 millimoles per litre (54 milligrams per decilitre) as a clinically important event that demands action. A severe event is defined not by a number but by the child's functional state: any hypoglycaemia associated with altered mental or physical status that requires another person to administer treatment. [1]

Clinically, the condition matters because the brain depends on glucose as its obligate fuel, and a child with type 1 diabetes has lost the insulin arm of the body's glucose-defence system and partially lost the glucagon arm as well. The result is that each episode is both an immediate emergency — a starved brain can seize and injure itself — and a signal that the therapy has outrun the physiology. The framing matters because it dictates management: the priority is to treat first and analyse the cause afterwards, because the recovery of the brain is time-critical and the analysis can wait. [3] [2]